Table 1.
Characteristics of Staphylococcus aureus strains.
| Strain | Isolation Source | Susceptibility Testing | Phenotypic Resistance | ||||
|---|---|---|---|---|---|---|---|
| GE | CIP | FOX | E | CC | |||
| S. aureus ATCC 43300 | ATCC (clinical isolate) | R | S | R | R | R | MRSA, cMLSB |
| 1 | Surgical wound | R | R | R | R | R | MRSA, cMLSB |
| 2 | BAL | R | R | R | R | R | MRSA, cMLSB |
| 3 | BAL | R | R | R | R | R | MRSA, cMLSB |
| 4 | Surgical wound | R | R | R | R | R | MRSA, iMLSB |
| 5 | Surgical wound | R | R | R | R | R | MRSA, cMLSB |
| 6 | Urine | R | R | R | R | R | MRSA, cMLSB |
| 7 | Surgical wound | R | R | R | R | R | MRSA, cMLSB |
| 8 | Surgical wound | R | R | R | R | R | MRSA, cMLSB |
ATCC—American Type Culture Collection, BAL—bronchoalveolar lavage, S—susceptible, R—resistant, GE—gentamicin, CIP—ciprofloxacin, FOX—cefoxitin, E—erythromycin, CC—clindamycin, MRSA—methicillin-resistant S. aureus, cMLSB—phenotypes expressing resistance to constitutive macrolides, lincosamides, and streptogramins B, iMLSB—phenotypes expressing resistance to inducible macrolides, lincosamides, and streptogramins B.